Harvey Weinstein—Lance Maerov's Corporate Governance Conflict

Harvey Weinstein—Lance Maerov's Corporate Governance Conflict was a struggle over what an independent director’s duty to protect The Weinstein Company required when evidence of Weinstein’s conduct threatened the business. Maerov tried to examine the record and impose contractual controls; Weinstein, with David Boies’s assistance, limited the review and retained his power. The conflict’s central contradiction was that the safeguards Maerov accepted were designed chiefly to protect the company from financial exposure, not to ensure that women would not be harassed or hurt.

A watchdog mandate

Appointed in 2013 to one of three independent seats on The Weinstein Company board, Maerov was expected to act as a watchdog. His appointment reflected the concerns of WPP, Goldman Sachs, and other major investors, who wanted someone to ensure that the Weinstein brothers did not harm shareholders. Maerov understood his assignment as corporate oversight, rather than a general mandate to investigate Weinstein’s treatment of women.

At first, he interpreted what he had heard about Weinstein through that limited frame. He knew rumors that Weinstein put friends in films and had noticed that young women often accompanied the producer at screenings and other events. Maerov took these as signs of extramarital relationships, not evidence of a pattern that might endanger employees. His attention was instead drawn to financial misconduct and the company’s broader dysfunction, including the public verbal fights between Harvey Weinstein and Bob Weinstein.

That distinction began to shift when an allegation of groping became public. Like Bob Weinstein, Maerov worried that Weinstein’s conduct might form a recurring pattern and expose the company to liability. The coming contract renewal gave him a formal opening: as one of the directors responsible for the process, he could seek to inspect Weinstein’s personnel file. What Maerov wanted to discover, and what Weinstein was willing to let the board see, became the immediate test of their relationship.

The blocked review

Weinstein refused to let Maerov examine the file. Boies offered to review it himself and report any potential legal problems to the board, but this arrangement deepened Maerov’s distrust. Boies sometimes presented himself as representing the company and sometimes as representing Weinstein; to Maerov, that created an apparent conflict over information that could be damaging to the producer.

On July 1, 2015, Maerov nevertheless got a brief look at material from the file. Irwin Reiter, the company accountant, and two other executives met him for breakfast at the Four Seasons Hotel in Beverly Hills. They outlined complaints of verbal abuse made over the years, and Reiter passed Maerov several pages containing the memo about Emily Nestor. The executives were taking a risk by showing him the documents and would not let him leave with them, so Maerov read the pages at the table. For a moment, he saw the kind of information he had been seeking; he did not, however, obtain the file or gain authority to conduct an independent review.

Maerov, Reiter, and Bob Weinstein each felt the situation could not continue as it was, but they did not act as a united bloc. Bob regarded Maerov as a threat to his own power. In the negotiations, Weinstein and Boies alternated pressure and persuasion, according to Maerov’s later account. Weinstein threatened to punch him at a film premiere. When Maerov complained, Boies characterized the complaint as exaggerated and questioned Maerov’s fitness to negotiate. A prominent corporate lawyer was then asked to review the personnel file and reported that it contained nothing that could create liability for the company. Maerov later learned that the reviewer’s son was a junior employee at The Weinstein Company.

Safeguards focused on liability

The review did not resolve Maerov’s concerns. Boies acknowledged that Weinstein had paid settlements to women, while emphasizing that company funds had not been used. Maerov did not pursue the details. He also discounted the Nestor memo, later explaining that it looked like a poor-quality copy and that it had come through colleagues rather than directly from Nestor. Those judgments helped him treat the question as addressed without establishing what had happened or whether the conduct might recur.

The contract produced a code of conduct and a schedule of escalating financial penalties if Weinstein’s misconduct led to settlements: $250,000 for the first settlement, $500,000 for the second, and up to $1 million. The agreement also allowed for Weinstein’s termination for misconduct. These provisions imposed costs on Weinstein and provided the company with formal protections, but they treated possible future allegations as liabilities to be priced and managed. Maerov’s principal concern was preventing damage to the corporation. Once he believed the company had legal protection and additional financial controls, he concluded that he had done enough.

The outcome showed the limits of his influence. In October 2015, Weinstein signed a new contract that secured his authority for years. With Boies’s help, he had outmaneuvered Maerov, Reiter, and Bob Weinstein. Reiter had considered ways to separate the brothers, had passed information to a director, and remained deeply troubled; Bob, meanwhile, accepted a private promise that Weinstein would continue intensive therapy for sex addiction after Boies persuaded him not to make treatment a written requirement. The contract’s enforceable penalties remained, but the therapeutic commitment did not.

The conflict returns in 2017

When Megan Twohey spoke with Maerov in 2017, he again faced a choice between assisting scrutiny and protecting the company. After their conversation, he called Bob Weinstein and company president David Glasser and relayed what Twohey had told him, despite having promised her otherwise. By the following morning, Weinstein had learned the details and asked Maerov to help stop the story. When Maerov balked, Weinstein threatened to use a letter Maerov had written to a former romantic partner. Maerov refused, maintaining that his responsibility was to safeguard The Weinstein Company, not Weinstein personally.

His refusal did not mean he had become an advocate for publication. The next day, Maerov emailed Weinstein that they needed a plan to protect the company if Twohey’s article ran. Later, outraged that Weinstein had retained lawyers and brought in Lanny Davis’s firm without informing the board, Maerov insisted on an emergency board conference call. The meeting’s immediate concern was the coming New York Times investigation and the company’s response. Boies told the directors it would be damaging and described eight to twelve settlements, while acknowledging that the total might be higher. He argued for a unified position rather than either defending Weinstein outright or terminating him.

What the conflict reveals

Maerov’s dealings with Weinstein were neither a straightforward story of successful oversight nor a complete absence of intervention. He sought access to records, received a brief and risky disclosure from Reiter, helped secure a code of conduct, and resisted Weinstein’s request to help suppress the 2017 story. Yet the file remained beyond his independent examination, the contract left Weinstein in power, and Maerov accepted assurances that reduced corporate exposure without demonstrating that women would be protected.

The relationship therefore turns on the gap between corporate accountability and individual safety. In 2015, allegations, settlements, and a memo could be translated into contractual risks, penalties, and termination terms; that translation made the problem legible to the board while leaving its underlying facts largely unexamined. In 2017, Maerov could oppose Weinstein’s attempt to enlist him personally and still frame his own next step as a plan to protect the company. His conflict with Weinstein exposed not only the producer’s resistance to oversight, but also how narrowly oversight could define the harm it was meant to address.